RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 78 filers reported holding RUBIUS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $169,000 | -64.1% | 17,455 | -33.7% | 0.01% | -73.0% |
| Q3 2021 | $471,000 | +40.2% | 26,321 | +91.4% | 0.04% | +32.1% |
| Q2 2021 | $336,000 | +232.7% | 13,749 | +3.2% | 0.03% | +154.5% |
| Q4 2020 | $101,000 | -44.5% | 13,323 | -63.4% | 0.01% | -8.3% |
| Q3 2020 | $182,000 | +2.8% | 36,363 | +22.7% | 0.01% | 0.0% |
| Q2 2020 | $177,000 | -33.0% | 29,642 | +6.9% | 0.01% | -25.0% |
| Q4 2019 | $264,000 | – | 27,739 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,618,351 | $11,652,000 | 19.67% |
| Flagship Pioneering Inc. | 38,296,526 | $170,419,000 | 7.99% |
| HARBOURVEST PARTNERS LLC | 986,878 | $4,392,000 | 2.12% |
| Abbot Financial Management, Inc. | 563,500 | $2,508,000 | 2.04% |
| Artal Group S.A. | 3,883,791 | $17,283,000 | 0.73% |
| ARK Investment Management | 318,121 | $1,416,000 | 0.04% |
| Walleye Capital LLC | 34,000 | $151,000 | 0.03% |
| Tekla Capital Management LLC | 155,982 | $694,000 | 0.03% |
| Baillie Gifford | 4,256,900 | $18,943,000 | 0.02% |
| FEDERATED HERMES, INC. | 600,000 | $2,670,000 | 0.01% |